Figure 2
From: Neoadjuvant chemotherapy reduces the levels of HMGB1 and E-cadherin in patients with breast cancer
Receiver operating characteristic (ROC) curves of HMGB1 and E-cadherin for the discrimination of a BC with and without favorable therapeutic responses to NACT.
